CloudCath logo — Saving Lives, One Infection at a Time.

CloudCath

Saving Lives, One Infection at a Time.

Founded 2017 United States San Francisco, United States 17 employees Series A Total: $12.00M

General Information

Company Name CloudCath
Founded Year 2017
Location United States San Francisco, United States
Employees 17
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with CloudCath. To contact CloudCath, visit cloudcath.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CloudCath

CloudCath is a digital health medical device company founded in 2017 with the slogan "Saving Lives, One Infection at a Time." The company is dedicated to remote complication monitoring for patients undergoing catheter-based treatments. It offers a remote monitoring platform that analyzes drainage fluid, using proprietary data analysis algorithms to detect fluid property deviations and automatically transmit notifications to healthcare providers, enabling earlier intervention in cases of catheter-associated complications such as infection. CloudCath's initial product targets patients undergoing peritoneal dialysis. The company, headquartered in San Francisco, received a $12.00M Series A investment on 13 February 2020, with major investors including Integral Capital Partners, StartX, Coconut Tree Investments, MBX Capital, The Capital Partnership, and FundRx. CloudCath is a member of the StartX Med Summer 2018 Cohort and a showcase company in the MedTech Innovator Summer 2019 cohort. It also received UCSF’s Rosenman Innovator award in 2018. With its focus on remote complication monitoring and strong investor backing from leading players in both healthcare and technology, CloudCath has positioned itself as a promising player in the digital health and medical device space.

Taxonomy: digital health, medical device, remote monitoring, complication monitoring, catheter-based treatments, remote patient care, MedTech, peritoneal dialysis, data analysis algorithms, early intervention, StartX Med, MedTech Innovator, UCSF Rosenman Innovator award, San Francisco

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $12.00M 6
Integral Capital Partners, StartX +4
13 Feb 2020
Seed Round Undisclosed 4
MedTech Innovator, Head and Heart Capital +2
17 Jun 2019
Convertible Note Undisclosed -
14 Dec 2018

CloudCath Alternatives & Competitors

CloudCath vs

A cardiopulmonary disease management solution provider

5 employees
AI, Manufacturing
CloudCath vs
CardioOne Connect
CardioOne Connect United States

Connected Solutions. Continuous Care.

Series A
28 employees
Biotechnology, IT
CloudCath vs
Grin®
Grin® United States

Teeth, Meet Tech. 🦷📱 We’re reinventing oral care for everyone.

Venture round
31 employees
Health Care, Health and Wellness

FAQ About CloudCath

Saving Lives, One Infection at a Time.
CloudCath was founded in 2017.
CloudCath is headquartered in San Francisco, United States.
CloudCath has approximately 17 employees.
CloudCath has completed 3 funding rounds, raising a total of $12.00M. The latest funding stage is Series A.
Top alternatives and competitors to CloudCath include SPACE (MedTech) Pte. Ltd. , CardioOne Connect, Grin®, Optimize EP. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CloudCath and SPACE (MedTech) Pte. Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CloudCath, https://bouncewatch.com/company/cloudcath, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes